Corbus Pharmaceuticals Holdings (CRBP) Debt to Equity (2013 - 2024)
Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Debt to Equity of $0.09 in Q2 2024, up 76157.01% quarter-over-quarter from $0.0 in Q1 2024, and down 92.83% on a YoY basis from $1.19 in Q3 2023.
Corbus Pharmaceuticals Holdings (CRBP) Debt to Equity (2013 - 2024) Analysis & Trends
Corbus Pharmaceuticals Holdings' Debt to Equity history runs 6 years deep, the most recent figure standing at $0.09 for Q2 2024.
- In Q2 2024, Debt to Equity fell 92.83% year-over-year to $0.09; the TTM figure through Jun 2024 stood at $0.09 (down 92.83% YoY), while the FY2023 annual figure was -$2.31, down 505.7% from the prior year.
- Debt to Equity was $0.09 for Q2 2024 at Corbus Pharmaceuticals Holdings, up from $0.0 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $1.19 in Q2 2023 to a low of -$2.31 in Q4 2023.
- Historically, Debt to Equity has averaged $0.24 across 5 years, with a median of $0.26 in 2021.
- Biggest YoY gain for Debt to Equity was 402.35% in 2023; the steepest drop was 505.7% in 2023.
- A 5-year view of Debt to Equity shows it stood at $0.42 in 2020, then plunged by 34.82% to $0.27 in 2021, then soared by 110.05% to $0.57 in 2022, then plunged by 505.7% to -$2.31 in 2023, then soared by 103.71% to $0.09 in 2024.
- The last three Debt to Equity figures came in at $0.09 (Q2 2024), $0.0 (Q1 2024), and -$2.31 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.32 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 133.67 Mn | 105.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 0.09 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | -2.31 |
| Sep 30, 2023 | 0.12 |
| Jun 30, 2023 | 1.19 |
| Mar 31, 2023 | 1.15 |
| Dec 31, 2022 | 0.57 |
| Sep 30, 2022 | 0.46 |
| Jun 30, 2022 | 0.24 |
| Mar 31, 2022 | 0.31 |
| Dec 31, 2021 | 0.27 |
| Sep 30, 2021 | 0.24 |
| Jun 30, 2021 | 0.25 |
| Mar 31, 2021 | 0.21 |
| Dec 31, 2020 | 0.42 |
| Sep 30, 2020 | 0.64 |
| Dec 31, 2013 | -0.20 |